Advisor, Staar Surgical
Search every verified Thomas Frinzi interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a September 2023 interview, Thomas Frinzi, Chair of the Board, President and CEO of STAAR Surgical, discussed the company's recent performance and developments. He stated that the company had a strong first quarter with 20 percent growth globally, noting that China, a major market, had recovered from a dip in late 2022, and that the U.S. market grew by 78 percent year over year. Frinzi said the company had invested in its U.S. team by adding practice development personnel, clinical applications staff, territory managers, and new executives, which he described as raising the quality of the team. Frinzi attributed increased adoption of the EVO ICL lens to expanded digital marketing and direct-to-consumer advertising, as well as the procedure's simplification due to the elimination of the peripheral iridotomy. He cited 99.4 percent patient satisfaction and two million implants worldwide, adding that no ophthalmologist had expressed dissatisfaction with the lens's quality of vision. Frinzi described the current period as an exciting time to be associated with STAAR Surgical.
“I think we're just coming off of a very strong first quarter where we had 20 percent growth and growth around the world. China's been a huge market for us and certainly took a little dip in late 2022 but China is clearly back. We've had tremendous growth in China, we've had growth in Europe and in the US we grew by 78...”
“Here closer to home in the U.S we've made a real conscious decision to invest in people and programs. We've added new practice development people, clinical applications people, territory managers and most recently added really high-end executives to continue to raise the bar in terms of the quality of our team.”
“One of the greatest assets any company can have is its people and as we make our people stronger and stronger it just bears fruit in so many ways. So it's an exciting time to be part of STAAR.”
“We are really pleased about the increase in adoption of the EVO ICL lens around the country. One of the things we have done is really double down on our digital marketing and in particular directed consumer marketing. We're spending a significant amount of money creating that brand awareness which then supports our exp...”
During the ASCRS meeting in San Diego, Mark Kontos, MD talked with Thomas G. Frinzi, Chair of the Board, President and Chief ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Thomas Frinzi.